Aidastra | Manufacturer of high-quality home care furniture. Our series includes CE, FDA, and SGS compliant rotating beds and rollator walkers. Trusted B2B factory providing international-standard mobility solutions.

Rotating Nursing Beds in the UK – MHRA Registration, CE Marking and NHS Continuing Healthcare

2026-10-26

Most export markets ask two questions. Can we sell this bed here, and will anyone pay for it. Britain asks a third one that catches suppliers out: who actually puts the bed in the room?

In the US, a funded bed is bought through a supplier and rented to the patient. In Germany, the Pflegekasse pays a fixed amount toward the bed and the family buys it. In England, a large share of the beds that reach people's homes arrive on loan from an NHS community equipment store — and those stores almost never stock a rotating bed. The payment question and the provision question sit in different places, run by different organisations, and a supplier who assumes one answer covers both will spend months quoting into a channel that does not exist.

The regulatory side also moved recently. On 21 October 2026 the UK government confirmed that CE-marked medical devices will be recognised in Great Britain on a long-term, indefinite basis. That removes a deadline that has hung over every European supplier since Brexit. What it does not remove is the domestic paperwork.

This guide covers both: what a rotating nursing bed needs to be legally placed on the GB market, which of the four payment routes can realistically fund one, and what the numbers say about the market behind all of it.

What changed on 21 October 2026

The consultation opened in February 2026 and closed in April; the response came out in October. The outcome matters more than the process.

Item	Position in Great Britain
CE marking under EU MDR / IVDR	Recognised indefinitely — no second approval route required
CE marking under the legacy EU MDD	Recognised until 31 December 2028, aligned with the EU transition
UKCA marking	Remains the domestic route; being modernised through the Medical Devices (Amendment) Regulations 2026, expected in force around autumn 2027
Role of UKCA going forward	Intended as a specialist route — first-in-market products, AI as a medical device — rather than a requirement for every product
Northern Ireland	EU MDR and IVDR apply directly under the Windsor Framework

Two practical readings of this, for a supplier already selling into the EU.

The first is that one certificate now serves both markets for the foreseeable future. If your EU notified-body certificate is valid, GB market access follows from it, which is a material saving in audit and testing time for a powered care bed.

The second is that the certificate's validity now carries more weight than it used to. GB access depends on the EU certificate staying alive. If a notified body suspends or withdraws it, both markets close at once. When you audit a supplier, check the certificate's current status and whether the notified body is still designated. A PDF on its own tells you neither.

What Great Britain still asks for, whatever the mark

Indefinite recognition changed the marking question. It did not touch the obligations that sit underneath it, and these are the ones that trip up first-time exporters.

Device registration with the MHRA. A manufacturer must register the device with the Medicines and Healthcare products Regulatory Agency before it is placed on the GB market, and keep that registration current. The registration is tied to the device and to the economic operator, so a change of manufacturer name or a new model needs to be reflected.

A UK Responsible Person. A manufacturer based outside the UK must appoint one before placing a device on the GB market. The UKRP is the MHRA's reachable counterparty: it registers the device, holds the technical documentation available for inspection, and is the party the regulator contacts when something goes wrong. Since 2021 this has been a hard requirement rather than a courtesy.

Post-market surveillance and reporting. Incidents go to the MHRA through the Yellow Card scheme, and the manufacturer is expected to run surveillance proportionate to the device's risk. For an electric bed with a rotation mechanism, the areas that generate reports are consistent across markets: entrapment and gap dimensions, handset behaviour during unintended activation, and battery backup performance during a power cut.

Labelling and instructions in English, with the UKRP's details on the device or its packaging. A CE-marked bed sold in Germany and then shipped to Britain without that change is not compliant, even though the certificate is.

Northern Ireland is a separate conversation. Under the Windsor Framework, NI follows EU rules, including EUDAMED registration and an EU authorised representative. A distributor covering the whole of the UK needs two sets of paperwork.

Which route the bed takes: medical device or furniture

This is the question UK buyers ask least often and should ask most. A bed for a home can be placed on the market under two different frameworks, and they carry different duties.

Route	Main standards	What it supports
Medical device	BS EN 60601-1, BS EN 60601-2-52, ISO 14971	Clinical positioning, care-home procurement, tender eligibility, incident reporting
Domestic furniture	BS EN 1725:2023, and the draft FprEN 17684:2025 for electric domestic beds	A home-furniture claim; assessed against furniture safety criteria

The furniture route is not a loophole, and suppliers who treat it as one create a liability for their dealers. It is a genuine category for beds designed and sold as domestic furniture, assessed on stability, edges, gaps, shear and compression points, and control behaviour. FIRA International, the UK furniture testing body, has published assessments against FprEN 17684:2025 for electric domestic beds, so the framework is in active use.

The choice decides what you may claim. A bed sold as furniture cannot carry clinical claims about patient handling or care outcomes, and it will not be accepted in a care-home tender that asks for 60601-2-52 evidence. A bed sold as a medical device carries the full obligations above — registration, UKRP, vigilance — and can be specified clinically.

The failure mode is a bed whose physical design is unchanged while its paperwork says two different things in two different markets. Before you import, ask the manufacturer which route the model is registered under in GB, and check that the instructions, labelling and marketing claims all match that answer.

Who pays: four routes, four different gatekeepers

Route	Who decides	What it covers	Realistic for a rotating bed?
Self-funding	The family	The whole bed, bought outright	Yes — the main channel
NHS Continuing Healthcare	The integrated care board, via a multidisciplinary assessment	A complete package of care for someone with a primary health need, which can include equipment	Possible, not routine; needs a primary health need, not a mobility need
NHS-funded Nursing Care	The NHS, paid to the care home	A flat contribution toward registered nursing in a care home	Not an equipment route
Local authority adult social care	The council, means-tested	Care and support, community equipment on loan, home adaptations	Rarely a rotating bed; standard equipment is the norm

Three details worth knowing, because they shape how a sale actually happens.

Continuing Healthcare is not a bed benefit. It is a funding decision about a person's overall health need, made against the National Framework. Where CHC is awarded, equipment can be part of the package, and a specialist bed is sometimes included. A family should not approach it as "apply for a bed". Where a care package already exists, though, a specialist bed can form part of it.

NHS-funded Nursing Care is money for nursing, not for kit. From 1 April 2026 the standard rate in England is £267.68 per week, with an enhanced rate of £368.24 for those who meet the higher criteria. It is paid to the care home. It tells you something about how nursing homes are funded, but it does not buy a bed.

Community equipment stores are the quiet gatekeeper. Local authorities and the NHS jointly run integrated community equipment services, which lend standard profiling beds, hoists and mattresses on loan, usually after a hospital discharge or an occupational therapy assessment. These services are efficient and heavily used, and their catalogues are standardised. A rotating bed is a specialist item that sits outside most of those contracts, which is why the UK self-pay market for one is larger than the funding statistics suggest.

The comparison that decides a self-funded purchase

For a family paying privately, the relevant number is what the alternative costs. LaingBuisson's 2025 market report puts the private-pay averages in England at £1,278 a week for residential care and £1,594 a week for nursing care — roughly £66,000 and £83,000 a year. The same report found one in seven independent nursing homes charging new admissions over £1,800 a week.

Against that, a mainstream rotating bed is a four-figure purchase made once, with a working life measured in years. The useful question for a family is how long the bed postpones a move that costs £1,600 a week.

Two limits on that comparison are worth stating plainly. A bed does not substitute for nursing care, and it will not keep someone at home who needs clinical supervision. It also only helps where the difficulty is the transfer itself — standing up, turning, getting the feet to the floor. For someone who is fully bed-bound, a good profiling bed with positioning functions does the job and costs less. Our guide to choosing a bed for home sets out how to tell those cases apart.

The workforce figure that drives the purchase

Skills for Care's 2025/26 report puts adult social care in England at 1.69 million posts, with 96,000 vacancies — a 6.2% vacancy rate, down from the post-pandemic peak but still roughly three times the wider economy. Turnover sits at 23.1%, and the sector is projected to need around 410,000 additional posts by 2040.

For a home-care provider, that number is a rota problem before it is a clinical one. A morning call that needs two carers because the client cannot get out of bed ties up twice the staff for the same visit. A bed that completes the transfer safely with one person standing by changes the staffing model for that visit, every day, across a whole round.

Care homes feel it differently: a bed that reduces manual handling lowers the risk of injury claims and the cost of agency cover when a carer is off sick. It also makes a room lettable to a resident whose transfer needs would otherwise rule it out.

The demand behind it

The Office for National Statistics puts the UK population at about 69.5 million, with roughly one in five people aged 65 or over and around 3% aged 85 or over. Projections point to about 71 million by 2034, with the 85-plus group growing fastest — the cohort most likely to need help with transfers.

That is the same demographic story as every other developed market, and it is why the UK is worth the paperwork. The difference is structural: a health service that supplies standard equipment on loan, a means-tested local authority system, and a large self-pay segment that sits between the two. Understanding that split is what makes the UK sellable. Treating Britain as "Europe with different plugs" tends to cost a year of discovery.

If you're importing or specifying

As a rotating nursing bed factory, we get asked for the same documents by UK dealers, and the list is short enough to check in an afternoon.

MHRA registration for the device, and the name and address of the UK Responsible Person.
The notified-body certificate for the EU MDR route, with its expiry date, plus confirmation that the body is still designated.
Which route the model is registered under in GB — medical device or domestic furniture — and marketing material that matches it.
The test evidence: IEC 60601-1 and IEC 60601-2-52 reports, not just a certificate of conformity.
Spare parts and service arrangements in the UK, including who attends a fault and how quickly.
A separate pack for Northern Ireland, since it follows EU rules.

If a supplier cannot say plainly which route a bed is registered under, that is the answer to a different question — and a reason to keep looking.

A short checklist before you ship to GB

Device registered with the MHRA, registration current
UK Responsible Person appointed, named on labelling
CE certificate valid, notified body still designated
English instructions and labelling, with UKRP details
PMS process in place; Yellow Card route understood
Service and spare-parts arrangements confirmed for the UK
Separate NI documentation under EU MDR
Marketing claims consistent with the regulatory route

Part of our market guide series on care equipment compliance. We build rotating beds and nursing beds at AIDASTRA; if you are comparing suppliers for the UK, the questions above work on any of them.

Sources

GOV.UK / MHRA — Timelines for acceptance of CE marked medical devices in Great Britain, and the government response to the targeted consultation on indefinite recognition of CE marking (published 21 October 2026). GOV.UK — CE marking timelines · Government response
MHRA — Regulating medical devices in the UK, including device registration and the UK Responsible Person requirement. GOV.UK — regulating medical devices
MHRA — Medical device stand-alone software and incident reporting via the Yellow Card scheme. Yellow Card
Department of Health and Social Care — NHS-funded Nursing Care standard rate for 2026/27: £267.68 per week from 1 April 2026 (enhanced rate £368.24). GOV.UK — nursing funding announcement
NHS England — National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care. NHS — continuing healthcare
LaingBuisson — Care Homes for Older People UK Market Report (35th edition, 2024/25 fee data): private-pay residential £1,278/week, nursing £1,594/week; one in seven independent nursing homes above £1,800/week. LaingBuisson press release
Skills for Care — The state of the adult social care sector and workforce in England, 2025/26: 1.69 million posts, 96,000 vacancies (6.2%), 23.1% turnover, 410,000 additional posts needed by 2040. Skills for Care
ONS — UK population estimates and national population projections. ONS — population estimates
BSI — BS EN 1725:2023, Furniture — Beds — Safety requirements and test methods. BSI
FIRA International — assessment of electric domestic beds against draft standard FprEN 17684:2025.